Screener
Orthofix Medical Inc. OFIX US — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Orthofix Medical Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333822
| (Unaudited, U.S. Dollars, in thousands, except per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $210,933 | $203,121 | $407,641 | $396,767 |
| Cost of sales | 61,226 | 63,588 | 118,388 | 135,615 |
| Gross profit | 149,707 | 139,533 | 289,253 | 261,152 |
| Sales, general, and administrative | 138,030 | 136,493 | 272,941 | 269,474 |
| Research and development | 15,944 | 15,934 | 31,264 | 35,700 |
| Acquisition-related amortization, impairment, and remeasurement (Note 11) | 3,867 | 3,109 | 7,618 | 20,854 |
| Operating loss | (8,134) | (16,003) | (22,570) | (64,876) |
| Interest expense, net | (6,085) | (3,950) | (11,749) | (8,456) |
Item 1. Financial Statements
FAQ
- What is Orthofix Medical Inc.'s US — revenue?
- Orthofix Medical Inc. (OFIX) reported US — revenue of $170.03M in Q2 2026.
- How has Orthofix Medical Inc.'s US — revenue changed year-over-year?
- Orthofix Medical Inc.'s US — revenue decreased by 1.0% year-over-year, from $171.74M to $170.03M.
- What is the long-term trend for Orthofix Medical Inc.'s US — revenue?
- Over 4 years (2021 to 2025), Orthofix Medical Inc.'s US — revenue has grown at a 17.3% compound annual growth rate (CAGR), from $361.95M to $684.07M.
- What does US — revenue mean?
- This metric represents the total net sales generated from the sale of medical devices and related services within the United States geographic segment, excluding any sales-based taxes. It serves as a primary indicator of the company's market penetration and demand for its orthopedic and spine solutions in the domestic market. Growth in this figure reflects successful commercial execution and the adoption of the company's product portfolio by healthcare providers.
Ask your AI about Orthofix Medical Inc.'s us — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude